DAVID POPLACK to Macaca mulatta
This is a "connection" page, showing publications DAVID POPLACK has written about Macaca mulatta.
Connection Strength
0.991
-
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
Score: 0.055
-
Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus. Drug Metab Dispos. 1983 Jan-Feb; 11(1):5-9.
Score: 0.047
-
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64.
Score: 0.038
-
A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res. 1977 Jul; 37(7 Pt 1):1982-5.
Score: 0.032
-
Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey. Invest New Drugs. 1993 Nov; 11(4):255-61.
Score: 0.025
-
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate. Invest New Drugs. 1993 May-Aug; 11(2-3):135-40.
Score: 0.024
-
Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam. Cancer Res. 1993 Apr 01; 53(7):1596-8.
Score: 0.024
-
Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993 Feb 15; 53(4):725-7.
Score: 0.024
-
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res. 1993 Feb 01; 53(3):472-6.
Score: 0.024
-
Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemother Pharmacol. 1993; 32(4):310-4.
Score: 0.024
-
Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 02; 84(17):1332-5.
Score: 0.023
-
Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys. J Clin Oncol. 1992 Aug; 10(8):1359-64.
Score: 0.023
-
Intrathecal 5-fluorouracil in the rhesus monkey. Cancer Chemother Pharmacol. 1992; 31(2):127-30.
Score: 0.022
-
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83.
Score: 0.022
-
Pharmacokinetics of pyrazoloacridine in the rhesus monkey. Cancer Res. 1991 Oct 15; 51(20):5467-70.
Score: 0.022
-
Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2. J Clin Oncol. 1991 Apr; 9(4):670-4.
Score: 0.021
-
Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9.
Score: 0.020
-
A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci. 1990 Sep; 40(5):520-5.
Score: 0.020
-
Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates. Antimicrob Agents Chemother. 1990 Jun; 34(6):1281-4.
Score: 0.020
-
Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys. Antimicrob Agents Chemother. 1989 Jun; 33(6):810-2.
Score: 0.018
-
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6.
Score: 0.018
-
Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates. Cancer Res. 1988 Aug 01; 48(15):4294-8.
Score: 0.017
-
Bioavailability of low-dose vs high-dose 6-mercaptopurine. Clin Pharmacol Ther. 1988 May; 43(5):588-91.
Score: 0.017
-
Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther. 1988 May; 245(2):466-70.
Score: 0.017
-
Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys. Cancer Res. 1988 Apr 15; 48(8):2113-5.
Score: 0.017
-
Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis. 1988 Jan; 157(1):178-80.
Score: 0.017
-
Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Cancer Res. 1987 Nov 15; 47(22):5932-4.
Score: 0.016
-
Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. Pain. 1987 Sep; 30(3):339-348.
Score: 0.016
-
Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7.
Score: 0.016
-
Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate. Cancer Drug Deliv. 1987; 4(1):25-31.
Score: 0.016
-
Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res. 1986 Dec; 46(12 Pt 1):6101-4.
Score: 0.015
-
Pharmacokinetics of trimetrexate (NSC 352122) in monkeys. Cancer Res. 1986 Jan; 46(1):169-74.
Score: 0.014
-
The effect of amitriptyline on the central nervous system penetration of methotrexate. Cancer Drug Deliv. 1986; 3(4):219-22.
Score: 0.014
-
Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys. Cancer Res. 1985 May; 45(5):2037-9.
Score: 0.014
-
Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am J Physiol. 1985 Feb; 248(2 Pt 2):R147-56.
Score: 0.014
-
Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Deliv. 1985; 2(4):247-53.
Score: 0.014
-
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984 Nov; 44(11):4929-32.
Score: 0.013
-
Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701.
Score: 0.013
-
Intrathecally administered m-AMSA in the rhesus monkey. Cancer Drug Deliv. 1984; 1(2):101-7.
Score: 0.013
-
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther. 1983 Dec; 34(6):810-7.
Score: 0.013
-
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9.
Score: 0.012
-
Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1982 May; 42(5):1736-9.
Score: 0.011
-
Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. J Natl Cancer Inst. 1982 Mar; 68(3):391-3.
Score: 0.011
-
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
Score: 0.011
-
Hypothalamic-adenohypophyseal function in male rhesus monkeys. A primate model. J Med Primatol. 1981; 10(2-3):61-71.
Score: 0.010
-
Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol. 1981; 5(4):257-60.
Score: 0.010
-
Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid. Pharmacology. 1981; 22(3):196-8.
Score: 0.010
-
Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates. Cancer Treat Rep. 1980 Apr-May; 64(4-5):734-6.
Score: 0.010
-
2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. Drug Metab Dispos. 1999 Oct; 27(10):1128-32.
Score: 0.009
-
Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model. J Pediatr Hematol Oncol. 1999 Jan-Feb; 21(1):26-30.
Score: 0.009
-
Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
Score: 0.009
-
Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys. Antimicrob Agents Chemother. 1995 Jun; 39(6):1259-64.
Score: 0.007
-
Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4.
Score: 0.007
-
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9.
Score: 0.007
-
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989; 28(1):59-66.
Score: 0.004
-
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos. 1987 Sep-Oct; 15(5):595-601.
Score: 0.004
-
Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. Neuroendocrinology. 1985 Jan; 40(1):84-7.
Score: 0.003
-
Inhibition of human lymphoproliferation by intravenous lipid emulsion. Clin Immunol Immunopathol. 1982 Nov; 25(2):196-202.
Score: 0.003
-
Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab. 1982 Jun; 54(6):1135-9.
Score: 0.003
-
Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. Cancer Treat Rep. 1982 Jun; 66(6):1333-41.
Score: 0.003
-
Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration. Eur J Cancer (1965). 1981 Jan; 17(1):29-34.
Score: 0.003
-
Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates. Cancer Res. 1980 Mar; 40(3):722-4.
Score: 0.002
-
Chronic ventricular cerebrospinal fluid sampling, drug injections, and pressure monitoring using subcutaneous reservoirs in monkeys. Neurosurgery. 1977 Sep-Oct; 1(2):132-5.
Score: 0.002
-
Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure. Science. 1977 Feb 04; 195(4277):499-501.
Score: 0.002